Revolution Medicines, Inc. |
Director |
Common Stock |
2.34M |
$89.9M |
$38.47 |
Jun 20, 2024 |
Direct |
Blueprint Medicines Corp |
Director |
Common Stock |
74.2K |
$7.8M |
$105.13 |
Jun 12, 2024 |
Direct |
Tango Therapeutics, Inc. |
Director |
Common Stock |
11.3K |
$85.6K |
$7.61 |
Jun 5, 2024 |
Direct |
Magenta Therapeutics, Inc. |
Director |
Common Stock |
4.1K |
$49.2K |
$12.00 |
Aug 26, 2021 |
Direct |
Revolution Medicines, Inc. |
Director |
Earn-out Shares |
296K |
|
|
Nov 9, 2023 |
Direct |
Relay Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
102K |
|
|
Jun 3, 2024 |
Direct |
Tango Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
37.5K |
|
|
Jun 5, 2024 |
Direct |
OPKO HEALTH, INC. |
Director |
Stock Option (Right to Buy) |
30K |
|
|
Jun 22, 2023 |
Direct |
Revolution Medicines, Inc. |
Director |
Stock Option (Right to Buy) |
16K |
|
|
Jun 20, 2024 |
Direct |
Blueprint Medicines Corp |
Director |
Stock Option (Right to Buy) |
4.57K |
|
|
Jun 12, 2024 |
Direct |
EQRx, Inc. |
Executive Chairman, Director |
Common Stock |
0 |
|
$2.21 |
Nov 9, 2023 |
Direct |
EQRx, Inc. |
Executive Chairman, Director |
Earn-out Shares |
0 |
|
|
Nov 9, 2023 |
Direct |
EQRx, Inc. |
Executive Chairman, Director |
Stock Option (Right to Buy) |
0 |
|
|
Nov 9, 2023 |
Direct |